-
Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures
This is a clinical research study of an investigational new drug device combination product of Staccato and alprazolam inhalation powder, called “Staccato ® alprazolam”. Staccato alprazolam ... -
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
The purpose of this study is to compare the effects of 2 different levels of exercise intensity and to learn more about effects of aerobic ... -
Efficacy and Safety of Lambda in Patients with Chronic Hepatitis Delta Virus (HDV) Infection (LIMT 2)
This is a study of an investigational drug (also known as the “study drug”) called Peginterferon Lambda-1a (Lambda) as a possible treatment for chronic hepatitis ... -
EMBER-4: A Randomized Open-Label Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+ HER2- Early Breast Cancer with an Increased Risk of Recurrence.
You can participate in this study if you are diagnosed with ER+, HER2- Early Breast Cancer (Stages I-III) with an Increased Risk of Recurrence. And ... -
A Phase 3 Open-Label Randomized Study of Lazertinib with Subcutaneous Amivantamab Administered via Manual Push Compared with Intravenous Amivantamab or Subcutaneous Amivantamab Administered via On Body Delivery System in Patients with EGFR-Mutated Advanced or Metastatic Non-Small Cell Lung Cancer After Progression on Osimertinib and Chemotherapy.
You can participate in this study if you are diagnosed with advanced lung cancer. The purpose of this study is to know the efficacy and ... -
Integrating Financial Coaching and Smoking Cessation Coaching
The purpose of this research study is to test a program that combines financial coaching with quit smoking coaching and nicotine replacement therapy (nicotine gum ... -
Impact Of Inclisiran on Major Adverse Cardiovascular Events in Participants with Established Cardiovascular Disease (VICTORION-2 PREVENT)
The purpose of this research study is to determine if the study treatment, an FDA approved drug known to be safe and effective in lowering ... -
ZEUS
A research study to look at how ziltivekimab works compared to placebo in people with cardiovascular disease, chronic kidney disease and inflammation.